Homes For Our Troops 4th Annual Veterans Day Celebrity Auction raises over $400,000 with Jake Tapper, George Clooney, Mindy Kaling, Wynonna Judd to support injured Veterans

Taunton, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) — TAUNTON, Mass.– The national nonprofit organization Homes For Our Troops (HFOT) raised over $400,000 during its 4th Annual Veterans Day Celebrity Auction on eBay from Nov. 10-17, 2020. Jake Tapper, George Clooney, Mindy Kaling, and Wynonna Judd headlined the event to support HFOT, which builds and donates specially adapted custom homes for severely injured post-9/11 Veterans, to enable them to rebuild their lives. In partnership with eBay for Charity, participants bid on personal Zoom experiences, luxury items, and autographed memorabilia from various movie stars, musicians, and sports figures, while helping HFOT’s mission.
 
CNN’s Jake Tapper, a longtime HFOT supporter and mission ambassador, enlisted the help of friends, namely movie stars and entertainment icons, to arrange an extensive assortment of auction items. There was tremendous support from over 120 celebrities donating items with over 7,500 bids placed. Tapper’s fellow Celebrity Auction co-host and actor George Clooney, generously donated his OMEGA Globemaster Watch to auction off and former world No. 1 professional tennis player Andy Roddick auctioned off a personal tennis lesson for three people, which was the highest bid item at $20,100. “I was honored to join the lineup for this year’s Celebrity Auction for the first time. HFOT is an extraordinary organization that provides injured Veterans with the life-changing gift of an adapted home and I am glad I was able to help this worthy cause.” – Andy Roddick.
 
“I’m so excited to have played a role in this auction alongside my co-hosts. We were concerned that because the global pandemic has precluded so many in-person activities, not to mention the devastating economic impact, that we might not have been able to raise as much this year. Thankfully, because of the very generous offers from so many actors, writers, athletes and more, and because of the generosity of participants, we raised more this year than ever before. So many people came together to help injured Veterans know: we care about you, we owe you, and we love you. “ – Jake Tapper.
 
The amount raised will go toward building more specially adapted custom homes for deserving Veterans across the country. Since its inception in 2004, HFOT has built and donated 312 homes in 42 states and has over 60 builds underway nationwide. Based on recent survey results from HFOT, over 95 percent of Veterans saw a reduction in household stress after receiving their adapted homes and over 90 percent report regaining much of their freedom and independence. HFOT Veterans saw a 99.5 percent increase in employment rate once in their homes, the increase was even higher for spouses/caregivers with a 285 percent increase. “We are ecstatic to have completed another successful auction with Jake Tapper and his team,” says HFOT President Tom Landwermeyer. “The funds raised through this event will truly make an impact in our mission of Building Homes and Rebuilding Lives. These homes enable severely injured Veterans to live independently and move forward in their recovery.”
 
Learn more about the impact of HFOT homes at www.hfotusa.org.
 
                                                                                   ##
About Homes For Our Troops (HFOT): Homes For Our Troops (HFOT) is a publicly funded 501(c) (3) nonprofit organization that builds and donates specially adapted custom homes nationwide to severely injured post-9/11 Veterans. Most of these Veterans have sustained life-altering injuries including multiple limb amputations, partial or full paralysis, and/or severe traumatic brain injury (TBI). These homes restore some of the freedom and independence our Veterans sacrificed while defending our country, and enable them to focus on their family, recovery, and rebuilding their lives. HFOT builds these homes where the Veteran chooses to live, and continues its relationship with the Veterans after home delivery to assist them with rebuilding their lives. Since its inception in 2004, nearly 90 cents of every dollar spent has gone directly to our program services supporting Veterans. For more information, visit www.hfotusa.org.



Renee Gugliotta
Homes For Our Troops
508-967-9016
[email protected]

Richmond Mutual Bancorporation, Inc. Announces Quarterly Dividend

PR Newswire

RICHMOND, Ind., Nov. 18, 2020 /PRNewswire/ — Richmond Mutual Bancorporation, Inc. (NASDAQ: RMBI) announced today that its Board of Directors has declared a cash dividend on Richmond Mutual Bancorporation common stock of $0.05 per share, payable on December 17, 2020 to stockholders of record as of the close of business on December 3, 2020. 

About Richmond Mutual Bancorporation, Inc.

Richmond Mutual Bancorporation, Inc., headquartered in Richmond, Indiana, is the holding company for First Bank Richmond, a community-oriented financial institution offering traditional financial and trust services within its local communities through its eight locations in Richmond, Centerville, Cambridge City and Shelbyville, Indiana, its five locations in Sidney, Piqua and Troy, Ohio and its loan production office in Columbus, Ohio.

Forward-Looking Statements

Statements in this press release that are not historical facts may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements often include words such as “believe,” “expect,” “anticipate,” “estimate,” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could,” or “may.” Forward-looking statements, by their nature, are subject to risks and uncertainties that could cause actual results to differ materially from the results anticipated in such statements, including the effect of the COVID-19 pandemic on the Company’s credit quality and business operations, as well as its impact on general economic and financial market conditions and other uncertainties such as the extent and duration of the impact of the pandemic on public health, the U.S. and global economies, and on consumer and corporate customers, employment levels and market liquidity.  In addition, forward-looking statements also are subject to legislative changes; changes in policies by regulatory agencies; fluctuations in interest rates; the risks of lending and investing activities, including changes in the level and direction of loan delinquencies and write-offs and changes in estimates of the adequacy of the allowance for loan losses; the Company’s ability to access cost-effective funding; fluctuations in real estate values and both residential and commercial real estate market conditions; demand for loans and deposits in the Company’s market area; changes in management’s business strategies; changes in the regulatory and tax environments in which the Company operates; and other factors set forth in the Company’s filings with the SEC. 

 

Cision View original content:http://www.prnewswire.com/news-releases/richmond-mutual-bancorporation-inc-announces-quarterly-dividend-301176484.html

SOURCE Richmond Mutual Bancorporation, Inc.

Palantir Enters Mission Command Space With US Army Futures Command Prototype

Palantir Enters Mission Command Space With US Army Futures Command Prototype

DENVER–(BUSINESS WIRE)–
Palantir Technologies (NYSE:PLTR) announced today it was chosen by the US Army to receive one of two prototype contracts for the Common Data Fabric and Data Security solution to support network design experimentation for the Army’s next network modernization set of technology, termed Capability Set 23.

This marks the first time Palantir’s Gotham software is being integrated with the Army’s latest mission command software application, called the Command Post Computing Environment (CPCE), making Palantir a key partner in accelerating the Army’s modernization. CPCE is now being fielded across the force, providing commanders with better visualization tools, common applications and new server infrastructure. The prototype will work at the intersection of intelligence, mission planning and execution, providing a single, integrated solution to give commanders a global operational picture to make better data-driven decisions.

The prototype effort, being executed by the Army’s Network-Cross Functional Team (N-CFT) and Program Executive Office – Command Control Communications Tactical (PEO-C3T), is another example of N-CFT and Army Futures Command’s commitment to modernizing the Army’s Mission Command capabilities through innovative acquisition. Palantir is proud to provide a prototype engagement that will allow the Army to inform network design decisions by assessing how modern data fabric and security solutions can enable enhanced situational awareness, improve command and control, and improve collaboration with joint, allied and coalition partners.

“We’re excited to partner with the N-CFT, and the PEO-C3T, on this important mission to modernize the Army’s Mission Command capabilities,” said Doug Philippone, Palantir’s Global Defense lead. “The Army’s proactive approach in seeking out opportunities to deploy commercially-available solutions has been instrumental in getting critical capabilities into the hands of warfighters faster.”

This is a two phased effort in which Palantir will configure its commercial solution for data management, a platform that is currently being used by hundreds of customers across government and commercial industries. The first phase starts with integration and testing in an Army laboratory lab before fielding and evaluation with user touchpoints and soldier feedback during phase two.

When this solution is eventually transitioned to production, this will ultimately improve access to critical data for commanders, deliver efficient use of networks in denied and degraded battlefield environments, and increase the ability to collaborate with joint and allied partners.

About Palantir Technologies Inc. Palantir Technologies is a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and nonprofit sectors transform the way they use their data. Additional information is available at https://www.palantir.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

Lisa Gordon

[email protected]

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Data Management Defense Security Technology Software Networks Contracts

MEDIA:

Logo
Logo

Aflac Incorporated Announces 17.9% Increase in the First Quarter 2021 Dividend

PR Newswire

COLUMBUS, Ga., Nov. 18, 2020 /PRNewswire/ — Aflac Incorporated (NYSE: AFL) today announced that its Board of Directors has declared the first quarter dividend of $0.33 per share, payable on March 1, 2021, to shareholders of record at the close of business on February 17, 2021. This represents a 17.9% increase over the previously declared fourth quarter dividend.

Commenting on the announcement, Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos said: “I am pleased with the Board’s action to increase the first quarter 2021 dividend. We treasure our record of 38 consecutive years of dividend increases, and we are looking to reward our shareholders by extending that track record in 2021. We remain committed to maintaining strong capital ratios on behalf of our policyholders and balance this financial strength with a focus on increasing the dividend, repurchasing shares and reinvesting in our business. Our dividend track record is supported by the strength of our capital and cash flows.” 

ABOUT AFLAC INCORPORATED

Aflac Incorporated (NYSE: AFL) is a Fortune 500 company, helping provide protection to more than 50 million people through its subsidiaries in Japan and the U.S., where it is a leading supplemental insurer by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated’s subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. Aflac Life Insurance Japan is the leading provider of medical and cancer insurance in Japan, where it insures 1 in 4 households. Fortune magazine recognized Aflac as one of the 100 Best Companies to Work for in America for 20 consecutive years. For 14 consecutive years, Aflac has been recognized by Ethisphere as one of the World’s Most Ethical Companies. In 2020, Fortune included Aflac Incorporated on its list of World’s Most Admired Companies for the 19th time, and Bloomberg added Aflac Incorporated to its Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency. To learn how to get help with expenses health insurance doesn’t cover, get to know us at aflac.com.

FORWARD-LOOKING INFORMATION

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The company desires to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as “expect,” “anticipate,” “believe,” “goal,” “objective,” “may,” “should,” “estimate,” “intends,” “projects,” “will,” “assumes,” “potential,” “target,” “outlook” or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.

The company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:


  • the effects of COVID-19 and any resulting economic effects and government interventions on the Company’s business and financial results
  • ability to attract and retain qualified sales associates, brokers, employees, and distribution partners
  • deviations in actual experience from pricing and reserving assumptions
  • ability to continue to develop and implement improvements in information technology systems
  • defaults and credit downgrades of investments
  • exposure to significant interest rate risk
  • concentration of business in Japan
  • limited availability of acceptable yen-denominated investments
  • tax rates applicable to the Company may change
  • failure to comply with restrictions on policyholder privacy and information security
  • interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems
  • catastrophic events including, but not necessarily limited to, epidemics, pandemics (such as the coronavirus COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events
  • ability to protect the Aflac brand and the Company’s reputation
  • extensive regulation and changes in law or regulation by governmental authorities
  • events related to the Japan Post investigation and other matters
  • competitive environment and ability to anticipate and respond to market trends
  • difficult conditions in global capital markets and the economy
  • foreign currency fluctuations in the yen/dollar exchange rate
  • decline in creditworthiness of other financial institutions
  • significant valuation judgments in determination of amount of impairments taken on the Company’s investments
  • U.S. tax audit risk related to conversion of the Japan branch to a subsidiary
  • subsidiaries’ ability to pay dividends to the Parent Company
  • decreases in the Company’s financial strength or debt ratings
  • inherent limitations to risk management policies and procedures
  • concentration of the Company’s investments in any particular single-issuer or sector
  • differing judgments applied to investment valuations
  • ability to effectively manage key executive succession
  • changes in accounting standards
  • level and outcome of litigation
  • allegations or determinations of worker misclassification in the United States

 

Analyst and investor contact – David A. Young, 706.596.3264 or 800.235.2667 or [email protected]

Media contact – Jon Sullivan, 706.763.4813 or [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/aflac-incorporated-announces-17-9-increase-in-the-first-quarter-2021-dividend-301176481.html

SOURCE Aflac Incorporated

EDAP Reports Third Quarter 2020 Results and Provides Operational Update

 

  • Generated strongest total revenue quarter of 2020
  • Reported growth in HIFU procedure revenues year-over-year notwithstanding ongoing COVID-19 pandemic
  • Completed sales to renowned healthcare institutions Mount Sinai Health System in New York and Keck Medical Center at the University of Southern California
  • Announced first patients treated in Phase 2 clinical trial assessing Focal One® as a potential treatment for deep rectal endometriosis
  • Increased strong cash position to EUR 19.9 million (USD 23.4 million) as of September 30, 2020
  • Company to host a conference call tomorrow, November 19th, at 8:30 am ET

LYON, France, November 18, 2020 — EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy based therapies, announced today financial results for the third quarter of 2020 and provided an update on strategic and operational developments. 

Marc Oczachowski, EDAP’s Chairman and Chief Executive Officer, said: “The third quarter of 2020 was our strongest of the year thus far, a clear signal that we are successfully navigating through the challenges posed by the ongoing COVID-19 pandemic. We closed several notable transactions during the quarter, including a bundled Focal One-ExactVu sale to Mount Sinai Health System in New York, and a Focal One sale to Keck Medical Center of University of Southern California, an early adopter of our first generation HIFU technology, Ablatherm®. At the same time, we continued to grow our sales pipeline, both in the U.S. and internationally.

“Also, during the quarter, we received regulatory approval to initiate a Phase 2 study assessing Focal One® as a potential treatment for deep rectal endometriosis and we initiated patient treatments quickly thereafter. Endometriosis represents an important expansion of our development pipeline as we work to maximize the clinical utility of HIFU across new indications beyond prostate.   

“We ended the quarter with a strong cash position of $23.4 million, sufficient to continue to execute on our Focal One-ExactVu commercial plan while advancing HIFU in endometriosis and other soft tissue indications where we believe this non-invasive technology can be beneficial.

“With COVID cases again rising in many parts of the world, including most of the US, we are carefully monitoring the effect on our operations during the fourth quarter. While we are seeing some impact on procedure volumes as hospitals continue to focus on the pandemic, we are nonetheless optimistic that we will be able to announce additional sales by the end of the year,” Mr. Oczachowski concluded.  

Third Quarter 2020 Results

Total revenue for the third quarter 2020 was EUR 9.4 million (USD 11.2 million), a decrease of 8.5% compared to total revenue of EUR 10.3 million (USD 11.3 million) for the same period in 2019. Third quarter 2020 revenue reflects the impact of the ongoing COVID-19 pandemic on equipment sales.

Total revenue in the HIFU business for the third quarter 2020 was EUR 2.6 million (USD 3.0 million), a 7.9% decrease compared to EUR 2.8 million (USD 3.1 million) for the third quarter of 2019.

Total revenue in the LITHO business for the third quarter 2020 was EUR 2.4 million (USD 2.9 million), a 27.6% decrease compared to EUR 3.3 million (USD 3.7 million) for the third quarter of 2019

Total revenue in the Distribution business for the third quarter 2020 was EUR 4.4 million (USD 5.2 million), a 6.4% increase compared to EUR 4.2 million (USD 4.6 million) for the third quarter of 2019.

Gross profit for the third quarter 2020 was EUR 4.0 million (USD 4.7 million), compared to EUR 4.7 million (USD 5.1 million) for the year-ago period. Gross profit margin on net sales was 42.0% in the third quarter of 2020, compared to 45.3% in the year-ago period. The decline in gross profit year-over-year was due to in part to lower sales in HIFU business as compared to the year-ago period driven primary by COVID-19.

Operating expenses were EUR 4.3 million (USD 5.0 million) for the third quarter of 2020, compared to EUR 4.4 million (USD 4.9 million) for the same period in 2019.

Operating loss for the third quarter of 2020 was EUR 0.3 million (USD 0.3 million), compared to an operating profit of EUR 0.3 million (USD 0.3 million) in the third quarter of 2019.

Net loss for the third of 2020 was EUR 1.0 million (USD 1.2 million), or EUR (0.03) per diluted share, as compared to net income of EUR 0.8 million (USD 0.9 million), or EUR 0.03 per diluted share in the year-ago period.

For the first nine months 2020 Results

Total revenue for the first nine months of 2020 was EUR 26.3 million (USD 29.8 million), a decrease of 20.1% compared to total revenue of EUR 32.9 million (USD 36.9 million) for the same period in 2019. As mentioned, year-to-date revenue reflects the impact of the ongoing COVID-19 pandemic on the company’s activities.

Total revenue in the HIFU business for the first nine months of 2020 was EUR 7.1 million (USD 8.0 million), a 37.2% decrease compared to EUR 11.2 million (USD 12.6 million) for the first nine months of 2019.

Total revenue in the LITHO business for the first nine months of 2020 was EUR 8.3 million (USD 9.4 million), a 17.8% decrease compared to EUR 10.1 million (USD 11.3 million) for the first nine months of 2019.

Total revenue in the Distribution business for the first nine months of 2020 was EUR 11.0 million (USD 12.4 million), a 5.6% decrease compared to EUR 11.6 million (USD 13.0 million) for the first nine month of 2019.

Gross profit for the first nine months of 2020 was EUR 11.4 million (USD 12.8 million), compared to EUR 15.9 million (USD 17.8 million) for the year-ago period. Gross profit margin on net sales was 43.2% for the first nine months of 2020, compared to 48.2% in the year-ago period. The decline in gross profit year-over-year was due in part to lower sales in the HIFU business driven by COVID-19.

Operating expenses were EUR 12.8 million (USD 14.5 million) for the first nine months of 2020, compared to EUR 13.7 million (USD 15.4 million) for the same period in 2019.

Operating loss for the first nine months of 2020 was EUR 1.5 million (USD 1.6 million), compared to an operating profit of EUR 2.1 million (USD 2.4 million) for the same period of 2019.

Net loss for the first nine months of 2020 was EUR 2.5 million (USD 2.8 million), or EUR (0.09) per diluted share, as compared to a net income of EUR 2.5 million (USD 2.8 million), or EUR 0.09 per diluted share in the year-ago period.

As of September 30, 2020, the Company recorded a strong cash position of EUR 19.9 million (USD 23.4 million).

  

Conference Call

An accompanying conference call and webcast will be conducted by management to review the results. The call will be held at 8:30am EDT tomorrow, November 19, 2020. Please refer to the information below for conference call dial-in information and webcast registration.

Conference Call & Webcast
Thursday, November 19, 2020 @ 8:30am Eastern Time


Domestic:                             877-451-6152
International:                      201-389-0879
Passcode:                             13712293
Webcast:                              http://public.viavid.com/index.php?id=142115

Following the live call, a replay will be available on the Company’s website, www.edap-tms.com under “Investors Information.”

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer.  EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com. Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, the clinical status and market acceptance of our HIFU devices and the continued market potential for our lithotripsy and distribution divisions, as well as the length and severity of the COVID-19 pandemic, including its impacts across our businesses on demand for our devices and services. Factors that may cause such a difference may also include, but are not limited to, those described in the Company’s filings with the Securities and Exchange Commission and in particular, in the sections “Cautionary Statement on Forward-Looking Information” and “Risk Factors” in the Company’s Annual Report on Form 20-F.

Company Contact

Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
[email protected]

Investor Contact

Jeremy Feffer
LifeSci Advisors, LLC
212-915-2568
[email protected]

EDAP TMS S.A.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands of Euros and U.S. Dollars, except per share data)

 
Three  Months Ended

:
 
Three Months Ended

:
    Sept. 30,

2020

Euros
 

 

Sept. 30,

2019

Euros
  Sept. 30,

2020

$US
  Sept. 30,

2019

$US
 
Sales of medical equipment 5,984   6,877   7,080   7,571  
Net Sales of RPP and Leases 1,207   1,228   1,428   1,352  
Sales of spare parts, supplies and Services 2,255   2,187   2,668   2,407  
TOTAL NET SALES 9,446   10,292   11,176   11,330  
Other revenues (13)   15   (16)   17  
TOTAL REVENUES 9,433   10,307   11,160   11,347  
Cost of sales (5,469)   (5,641)   (6,470)   (6,209)  
GROSS PROFIT 3,964   4,667   4,690   5,137  
Research & development expenses (1,090)   (886)   (1,289)   (975)  
S, G & A expenses (3,167)   (3,522)   (3,748)   (3,877)  
Total operating expenses (4,257)   (4,408)   (5,037)   (4,852)  
OPERATING PROFIT (LOSS) (293)   259   (347)   285  
Interest (expense) income, net (12)   (40)   (14)   (44)  
Currency exchange gains (loss), net (574)   684   (679)   753  
INCOME (LOSS) BEFORE TAXES AND MINORITY INTEREST (879)   903   (1,040)   994  
Income tax (expense) credit (122)   (120)   (145)   (132)  
NET INCOME (LOSS)

 

(1,001)   783   (1,185)   862  
Earning per share – Basic (0.03)   0.03   (0.04)   0.03  
Average number of shares used in computation of EPS 29,144,010   28,997,886   29,144,010   28,997,886  
Earning per share – Diluted (0.03)   0.03   (0.04)   0.03  
Average number of shares used in computation of EPS for positive net income

 

29,144,010   29,622,866   29,144,010   29,622,866  

NOTE:  Translated for convenience of the reader to U.S. dollars at the 2020 average three months’ noon buying rate of 1 Euro = 1.1832 USD, and 2019 average three months noon buying rate of 1 Euro = 1.1008 USD

EDAP TMS S.A.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands of Euros and U.S. Dollars, except per share data)

 
Nine Months Ended

:
 
Nine Months Ended

:
    Sept. 30,

2020

Euros
 

 

Sept. 30,

2019

Euros
  Sept. 30,

2020

$US
  Sept. 30,

2019

$US
 
Sales of medical equipment 16,083   22,139   18,204   24,797  
Net Sales of RPP and Leases 3,409   4,028   3,858   4,512  
Sales of spare parts, supplies and Services 6,795   6,742   7,691   7,551  
TOTAL NET SALES 26,287   32,909   29,753   36,860  
Other revenues 11   15   12   17  
TOTAL REVENUES 26,298   32,924   29,765   36,877  
Cost of sales (14,948)   (17,061)   (16,919)   (19,110)  
GROSS PROFIT 11,350   15,863   12,846   17,768  
Research & development expenses (3,058)   (2,884)   (3,461)   (3,231)  
S, G & A expenses (9,743)   (10,857)   (11,027)   (12,161)  
Total operating expenses (12,800)   (13,742)   (14,488)   (15,392)  
OPERATING PROFIT (LOSS) (1,451)   2,121   (1,642)   2,376  
Interest (expense) income, net (51)   (103)   (58)   (115)  
Currency exchange gains (loss), net (631)   788   (714)   883  
INCOME (LOSS) BEFORE TAXES AND MINORITY INTEREST (2,133)   2,807   (2,415)   3,144  
Income tax (expense) credit (351)   (317)   (397)   (356)  
NET INCOME (LOSS)

 

(2,484)   2,490   (2,812)   2,789  
Earning per share – Basic (0.09)   0.09   (0.10)   0.10  
Average number of shares used in computation of EPS 29,142,788   28,997,866   29,142,788   28,997,866  
Earning per share – Diluted (0.09)   0.08   (0.10)   0.09  
Average number of shares used in computation of EPS for positive net income

 

29,142,788   29,623,683   29,142,788   29,623,683  

NOTE:  Translated for convenience of the reader to U.S. dollars at the 2020 average nine months’ noon buying rate of 1 Euro = 1.1319 USD, and 2019 average nine months noon buying rate of 1 Euro = 1.1201 USD 

EDAP TMS S.A.

UNAUDITED CONSOLIDATED BALANCE SHEETS HIGHLIGHTS

(Amounts in thousands of Euros and U.S. Dollars)

    Sept. 30,

2020

Euros
 

 

June. 30,

2020

Euros
  Sept. 30,

2020

$US
  June 30,

2020

$US
Cash, cash equivalents and short-term treasury investments 19,929   15,704   23,364   17,647  
Account receivables, net 11,572   12,607   13,567   14,167  
Inventory 9,455   9,365   11,084   10,523  
Other current assets 604   631   708   709  
TOTAL CURRENT ASSETS 41,560   38,307   48,722   43,046  
Property, plant and equipment, net 5,928   6,072   6,950   6,823  
Goodwill 2,412   2,412   2,827   2,710  
Other non-current assets 1,739   1,794   2,039   2,016  
TOTAL ASSETS 51,639   48,585   60,538   54,596  
Accounts payable & other accrued liabilities 9,122   9,618   10,694   10,808  
Deferred revenues, current portion 2,695   2,519   3,160   2,831  
Short term borrowing 1,459   887   1,711   997  
Other current liabilities 5,825   1,820   6,829   2,045  
TOTAL CURRENT LIABILITIES 19,102   14,845   22,394   16,681  
Obligations under operating and finance leases non-current 1,724   1,906   2,021   2,141  
Long term debt, non-current 1,219   1,193   1,429   1,341  
Deferred revenues, non-current 821   1,100   963   1,236  
Other long term liabilities 3,626   3,673   4,251   4,128  
TOTAL LIABILITIES 26,493   22,717   31,059   25,528  
TOTAL SHAREHOLDERS’EQUITY 25,146   25,867   29,480   29,068  
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY 51,639    48,585   60,538   54,596  

NOTE: Translated for convenience of the reader to U.S. dollars at the noon buying rate of 1 Euro = 1.1723 USD, on September 30, 2020 and at the noon buying rate of 1 Euro = 1.1237 USD, on June 30, 2020.

EDAP TMS S.A.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands of Euros)

  Sept. 30, 2020

Euros
    June 30, 2020

      Euros
  Sept. 30, 2020

$US
  June 30      2020

$US
NET INCOME (LOSS) (2,484)   (1,483)   (2,812)   (1,640)
Adjustments to reconcile net income (loss) to net cash generated by (used in) operating activities 2,211       1,457       2,503       1,612
OPERATING CASH FLOW (273)   (25)   (309)   (28)
Increase/Decrease in operating assets and liabilities (1,735)   (1,774)   (1,964)   (1,963)
NET CASH GENERATED BY (USED IN) OPERATING ACTIVITIES (2,008)   (1,799)   (2,273)   (1,991)
Short term investments(1) (1,708)   (1,786)   (1,933)   (1,976)
Additions to capitalized assets produced by the company and other capital expenditures (1,508)   (844)   (1,707)   (933)
NET CASH GENERATED BY (USED IN) INVESTING ACTIVITIES (3,216)   (2,630)   (3,640)   (2,909)
NET CASH GENERATED BY (USED IN) FINANCING ACTIVITIES 2,248   (2,444)   2,544   (2,704)
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS 312   (44)   1,281   (204)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (2,665)   (6,968)   (2,088)   (7,808)

(1)
Short term investments are comprised of money market funds

NOTE:  Translated for convenience of the reader to U.S. dollars at the 2020 average nine months’ noon buying rate of 1 Euro = 1.1319 USD, and 2019 average nine months noon buying rate of 1 Euro = 1.1201 USD 


 

  

EDAP TMS S.A.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS BY DIVISION

NINE MONTHS ENDED SEPTEMBER 30, 2020

(Amounts in thousands of Euros)

     

HIFU
Division

   

ESWL
Division

   

Distribution
Division

   

Reconciling
Items

   

Total After Consolidation

 
 

Sales of goods

 

3,095

   

3,408

   

9,580

       

16,083

 
Sales of RPPs & Leases 2,594   659   156       3,409  
Sales of spare parts & services 1,351   4,217   1,226       6,795  
TOTAL NET SALES

 

7,041   8,284   10,962       26,287  
Other revenues

 

11   0   0       11  
TOTAL REVENUES 7,052   8,284   10,962       26,298  
GROSS PROFIT

(% of Total Revenues)
3,877 55.0 % 3,490 42.1% 3,982 36.3%     11,350 43.2%
 

Research & Development

 

(1,763)

  (1,006)   (289)       (3,058)  
Total SG&A plus depreciation (2,870)   (2,154)   (3,599)   (1,119)   (9,743)  
 

OPERATING PROFIT (LOSS)

 

(756)

   

331

   

94

   

(1,119)

   

(1,451)

 

 

Attachment



MVB Financial Corp. Declares Fourth Quarter 2020 Dividend

MVB Financial Corp. Declares Fourth Quarter 2020 Dividend

FAIRMONT, W.Va.–(BUSINESS WIRE)–
MVB Financial Corp. (NASDAQ: MVBF) (“MVB Financial” or “MVB”) has declared a quarterly cash dividend of $0.09 per share payable on December 15, 2020, to shareholders of record at the close of business on December 1, 2020, maintaining the dividend declared in the previous quarter.

This is the fourth quarterly dividend for 2020, totaling $0.36 per share payout for the year.

“Our third quarter 2020 results were remarkable despite the challenging operating dynamics that continued throughout the quarter. Team MVB remained intensely focused on executing actions to maximize success during these uncertain times. In doing so, we saw notable, consistent growth on several fronts, including noninterest-bearing deposits, net income and tangible book value. We are pleased to maintain our current dividend level for shareholders and, as always, are dedicated to their success,” said Larry F. Mazza, President and CEO, MVB Financial Corp.

About MVB Financial Corp.

MVB Financial Corp. (“MVB Financial” or “MVB”), the holding company of MVB Bank, is publicly traded on The Nasdaq Capital Market® under the ticker “MVBF.” Nasdaq is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its subsidiary, MVB Bank, Inc., and the Bank’s subsidiaries, MVB Mortgage, MVB Community Development Corporation, MVB Technology, Chartwell Compliance and Paladin Fraud, the company provides financial services to individuals and corporate clients in the Mid-Atlantic region and beyond. For more information about MVB, please visit ir.mvbbanking.com.

Forward-looking Statements

MVB Financial Corp. (the “Company”) has made forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in this Press Release. These forward-looking statements are based on current expectations about the future and subject to risks and uncertainties. Forward-looking statements include, without limitation, information concerning possible or assumed future results of operations of the Company and its subsidiaries. When words such as “may,” “plans,” “believes,” “expects,” “anticipates,” “continues,” “may” or similar expressions occur in this Dividend Press Release, the Company is making forward-looking statements. Note that many factors could affect the future financial results of the Company and its subsidiaries, both individually and collectively, and could cause those results to differ materially from those expressed in the forward-looking statements contained in this Dividend Press Release. Additional factors that may cause actual results to differ materially from those described in the forward-looking statements can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, as well as its other filings with the SEC, which are available on the SEC website at www.sec.gov. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements.

MEDIA CONTACT

Amy Baker

VP, Corporate Communications and Marketing

MVB Bank

[email protected]

(844) 682-2265

INVESTOR RELATIONS

Marcie Lipscomb

[email protected]

(844) 682-2265

KEYWORDS: West Virginia United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

TOP RANKED GLOBALLY RECOGNIZED ROSEN LAW FIRM, Commences Investigation of Securities Claims Against JOYY Inc. Seeking Recovery of Investor Losses; Encourages Investors with Losses Over $100K to Seek Counsel – YY

TOP RANKED GLOBALLY RECOGNIZED ROSEN LAW FIRM, Commences Investigation of Securities Claims Against JOYY Inc. Seeking Recovery of Investor Losses; Encourages Investors with Losses Over $100K to Seek Counsel – YY

NEW YORK–(BUSINESS WIRE)–
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of JOYY Inc. (NASDAQ: YY) resulting from allegations that JOYY may have issued materially misleading business information to the investing public.

On November 18, 2020, Muddy Waters Research published a report entitled “YY: You Can’t Make This Stuff Up. Well…Actually You Can[.]” The Muddy Waters report described a series of issues involving JOYY, stating that the Company “is a multibillion-dollar fraud.” Further, the Muddy Waters report stated “We conclude that YY’s component businesses are a fraction of the size it reports, and that the company’s reported user metrics, revenues, and cash balances are predominantly fraudulent[,]” and that “[a]pproximately 84% of YY’s reported consolidated revenue appears to be fraudulent.”

On this news, JOYY American depositary shares (“ADSs”) price fell $26.53 per ADS, or 26%, to close at $73.66 per ADS on November 18, 2020.

Rosen Law Firm is preparing a securities lawsuit on behalf of JOYY shareholders. If you purchased securities of JOYY please visit the firm’s website at http://www.rosenlegal.com/cases-register-1988.html to join the securities action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Banc of California Announces Quarterly Dividends

Banc of California Announces Quarterly Dividends

SANTA ANA, Calif.–(BUSINESS WIRE)–
Banc of California, Inc. (NYSE: BANC), today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share on its outstanding common stock. The dividend will be payable on January 4, 2021 to stockholders of record as of December 15, 2020.

Banc of California maintains a Dividend Reinvestment Plan (DRIP) which allows stockholders to automatically acquire shares at a 3% discount from the applicable market price. All registered stockholders with holdings maintained at the Company’s transfer agent, Computershare, are eligible to participate in the DRIP program. For more information on the Company’s DRIP program, please contact Investor Relations at [email protected] or (855) 361-2262.

The Board of Directors also declared a quarterly dividend of $0.460938 per depository share on the Company’s 7.375% Series D Non-Cumulative Perpetual Preferred Stock. The dividend will be payable on December 15, 2020 to holders of record as of November 30, 2020. The Series D depository shares are traded on the New York Stock Exchange under the “BANC PRD” symbol.

The Board of Directors also declared a quarterly dividend of $0.4375 per depository share on the Company’s 7.00% Series E Non-Cumulative Perpetual Preferred Stock. The dividend will be payable on December 15, 2020 to holders of record as of November 30, 2020. The Series E depository shares are traded on the New York Stock Exchange under the “BANC PRE” symbol.

About Banc of California, Inc.

Banc of California, Inc. (NYSE: BANC) is a bank holding company with approximately $7.7 billion in assets and one wholly-owned banking subsidiary, Banc of California, N.A. (the “Bank”). The Bank has 39 offices including 31 full-service branches located throughout Southern California. Through our dedicated professionals, we provide customized and innovative banking and lending solutions to businesses, entrepreneurs and individuals throughout California. We help to improve the communities where we live and work, by supporting organizations that provide financial literacy and job training, small business support and affordable housing. With a commitment to service and to building enduring relationships, we provide a higher standard of banking. We look forward to helping you achieve your goals. For more information, please visit us at www.bancofcal.com

Investor Relations Inquiries:

Banc of California, Inc.

(855) 361-2262

Jared Wolff, (949) 385-8700

Lynn Hopkins, (949) 265-6599

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Small Business Banking Professional Services Finance

MEDIA:

Logo
Logo

CNO Financial Group Announces Pricing of $150 Million Subordinated Debentures Offering

PR Newswire

CARMEL, Ind., Nov. 18, 2020 /PRNewswire/ — CNO Financial Group, Inc. (NYSE: CNO) announced today the pricing of its registered public offering of $150 million in aggregate principal amount of 5.125% subordinated debentures due 2060 (the “Debentures”). Completion of the offering is expected to occur on November 25, 2020, subject to customary closing conditions.

The Debentures will bear interest at an annual rate of 5.125%, payable quarterly in arrears on February 25, May 25, August 25 and November 25 commencing on February 25, 2021. The Debentures will mature on November 25, 2060.

CNO intends to use the net proceeds from the offering of the Debentures for general corporate purposes.

BofA Securities, Inc., RBC Capital Markets, LLC and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering of the Debentures.

The Debentures are being offered pursuant to CNO’s shelf registration statement, which is available online at www.sec.gov. A preliminary prospectus supplement and accompanying prospectus describing the terms of the offering have been filed with the Securities and Exchange Commission, and may be obtained online at www.sec.gov or from: BofA Securities, Inc., Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, North Carolina 28255, by phone at 1-800-294-1322 or by email at [email protected]; RBC Capital Markets, LLC, Attention: DCM Transaction Management, 200 Vesey Street, 8th Floor New York, New York 10281, or by phone at (866) 375-6829 or Wells Fargo Securities, LLC Attention: WFS Customer Service, 608 2nd Avenue South, Suite 1000, Minneapolis, Minnesota 55402, by phone at 1-800-645-3751 or by email at [email protected].

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Debentures or any other securities, nor shall there be any sale of the Debentures in any state or jurisdiction, in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Cautionary Statement Regarding Forward-Looking Statements

Our statements, trend analyses and other information contained in this press release and elsewhere (such as in filings by CNO with the Securities and Exchange Commission (the “SEC”), press releases, presentations by CNO or its management or oral statements) relative to markets for CNO’s products and trends in CNO’s operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995.  Forward-looking statements typically are identified by the use of terms such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “project,” “intend,” “may,” “will,” “would,” “contemplate,” “possible,” “attempt,” “seek,” “should,” “could,” “goal,” “target,” “on track,” “comfortable with,” “optimistic,” “guidance,” “outlook” and similar words, although some forward-looking statements are expressed differently.  You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other “forward-looking” information based on currently available information.  The “Risk Factors” section of our 2019 Annual Report on Form 10-K and the changes set forth in the Risk Factors section of our Form 10-Qs provide examples of risks, uncertainties and events that could cause our actual results to differ materially from the expectations expressed in our forward-looking statements.  Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things: the ongoing COVID-19 pandemic and the resulting financial market, economic and other impacts could adversely affect our business, results of operations, financial condition and liquidity; changes in or sustained low interest rates causing reductions in investment income, the margins of our fixed annuity and life insurance businesses, and sales of, and demand for, our products; expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products; general economic, market and political conditions and uncertainties, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so; the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject; our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products; our ability to obtain adequate and timely rate increases on our health products, including our long-term care business; the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries; mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates, changes in the health care market and other factors which may affect the profitability of our insurance products; changes in our assumptions related to deferred acquisition costs or the present value of future profits; the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value; our assumption that the positions we take on our tax return filings will not be successfully challenged by the Internal Revenue Service; changes in accounting principles and the interpretation thereof; our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements; our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems; performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges); our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition; our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs; changes in capital deployment opportunities; our ability to maintain effective controls over financial reporting; our ability to continue to recruit and retain productive agents and distribution partners; customer response to new products, distribution channels and marketing initiatives; our ability to maintain the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital; regulatory changes or actions, including: those relating to regulation of the financial affairs of our insurance companies, such as the calculation of risk-based capital and minimum capital requirements, and payment of dividends and surplus debenture interest to us; regulation of the sale, underwriting and pricing of products; and health care regulation affecting health insurance products; changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets; availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform; the performance of third party service providers and potential difficulties arising from outsourcing arrangements; the growth rate of sales, collected premiums, annuity deposits and assets; interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems; events of terrorism, cyber attacks, natural disasters or other catastrophic events, including losses from a disease pandemic or potential adverse impacts from global warming; ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and the risk factors or uncertainties listed from time to time in our filings with the SEC.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cno-financial-group-announces-pricing-of-150-million-subordinated-debentures-offering-301176478.html

SOURCE CNO Financial Group, Inc.

Wyndham Hotels & Resorts Declares Quarterly Cash Dividend

PR Newswire

PARSIPPANY, N.J., Nov. 18, 2020 /PRNewswire/ — Wyndham Hotels & Resorts, Inc. (NYSE: WH) announced today its Board of Directors declared a quarterly cash dividend of $0.08 per share on its common stock, payable December 30, 2020 to shareholders of record as of December 15, 2020.


About Wyndham Hotels & Resorts


Wyndham Hotels & Resorts (NYSE: WH) is the world’s largest hotel franchising company by the number of properties, with approximately 9,000 hotels across approximately 90 countries on six continents. Through its network of 804,000 rooms appealing to the everyday traveler, Wyndham commands a leading presence in the economy and midscale segments of the lodging industry. The Company operates a portfolio of 20 hotel brands, including Super 8®, Days Inn®, Ramada®, Microtel®, La Quinta®, Baymont®, Wingate®, AmericInn®, Hawthorn Suites®, Trademark Collection® and Wyndham®. Wyndham Hotels & Resorts is also a leading provider of hotel management services. The Company’s award-winning Wyndham Rewards loyalty program offers 85 million enrolled members the opportunity to redeem points at thousands of hotels, vacation club resorts and vacation rentals globally. For more information, visit www.wyndhamhotels.com. The Company may use its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Disclosures of this nature will be included on the Company’s website in the Investors section, which can currently be accessed at www.investor.wyndhamhotels.com. Accordingly, investors should monitor this section of the Company’s website in addition to following the Company’s press releases, filings submitted with the Securities and Exchange Commission and any public conference calls or webcasts.


Forward-Looking Statements


This press release contains “forward-looking statements” within the meaning of federal securities laws, including statements related to Wyndham Hotels’
 quarterly dividend
.  Forward-looking statements include those that convey management’s expectations as to the future based on plans, estimates and projections at the time Wyndham Hotels makes the statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Wyndham Hotels to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, general economic conditions; the continuation or worsening of the effects from the COVID-19 pandemic, its scope, duration and impact on the Company’s business operations, financial results, cash flows and liquidity, as well as the impact on the Company’s franchisees and property owners, guests and team members, the hospitality industry and overall demand for travel; the success of the Company’s mitigation efforts in response to the COVID-19 pandemic;
the Company’s performance in any recovery from the COVID-19 pandemic; the performance of financial and credit markets; the economic environment for the hospitality industry; operating risks associated with the hotel franchising and management businesses; the Company’s relationships with franchisees and property owners; the impact of war, terrorist activity or political strife; concerns with or threats of pandemics, contagious diseases or health epidemics, including the effects of the COVID-19 pandemic and any resurgence of the virus and actions governments, businesses and individuals take in response to the pandemic, including stay-in-place directives and other travel restrictions; risks related to the acquisition of La Quinta and the Company’s relationship with CorePoint Lodging; the Company’s ability to satisfy obligations and agreements under its outstanding indebtedness, including the payment of principal and interest and compliance with the covenants thereunder; risks related to the Company’s ability to obtain financing and the terms of such financing,
including access to liquidity and capital as a result of COVID-19; and the Company’s limitations related to share repurchases and ability to pay dividends under its credit facility and the timing and amount of any future dividends, as well as the risks described in the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission and any subsequent reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, subsequent events or otherwise.



Contacts


Investors:                                                              

Matt Capuzzi

Senior Vice President, Investor Relations

973 753-6453


[email protected]

 


Media: 

Dave DeCecco
Group Vice President, Global Communications  973 753-7474 
[email protected]

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/wyndham-hotels–resorts-declares-quarterly-cash-dividend-301176452.html

SOURCE Wyndham Hotels & Resorts